Sort   by:  
 Page size 
UnknownA 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores.
Not available
S-EPMC12820744 | biostudies-literature
UnknownA phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease).
Not available
S-EPMC12535634 | biostudies-literature
UnknownAnalysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients.
Not available
S-EPMC3821872 | biostudies-literature
UnknownTNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy.
Not available
S-EPMC3220654 | biostudies-literature
UnknownATM polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
Not available
S-EPMC3594431 | biostudies-literature
UnknownGenotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy.
Not available
S-EPMC2939547 | biostudies-literature
UnknownCancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy.
Not available
S-EPMC7640696 | biostudies-literature
UnknownIncidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases.
Not available
S-EPMC11817078 | biostudies-literature
UnknownA risk analysis of alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast cancer.
Not available
S-EPMC10913434 | biostudies-literature
UnknownTamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.
Not available
S-EPMC4772450 | biostudies-literature
Sort   by:  
 Page size